Attached files
| file | filename |
|---|---|
| 10-Q/A - FORM 10-Q/A - Viridian Therapeutics, Inc.\DE | f10qa_121714.htm |
| EX-10.2 - EXHIBIT 10.2 - Viridian Therapeutics, Inc.\DE | exh_102.htm |
| EX-31.1 - EXHIBIT 31.1 - Viridian Therapeutics, Inc.\DE | exh_311.htm |
| EX-10.3 - EXHIBIT 10.3 - Viridian Therapeutics, Inc.\DE | exh_103.htm |
Exhibit 31.2
CERTIFICATIONS
I, Tamara A. Seymour, certify that:
1. I have reviewed this Amendment No. 1 to Form 10-Q of Signal Genetics, Inc., a Delaware corporation; and
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
|
Dated: December 23, 2014
|
|
| /s/ Tamara A. Seymour | |
|
Tamara A. Seymour
|
|
|
Chief Financial Officer (Principal Financial Officer)
|